Sei Investments CO Tekla Life Sciences Investors Transaction History

Sei Investments CO

$69 Billion
Q2 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 08, 2018	SELL	$18.89 - $20.49 $9,142 - $9,917	-484 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$18.13 - $19.4 $362 - $388	20 Added 4.31%	484 $9,000
Q1 2018 May 11, 2018	BUY	$18.92 - $21.52 $813 - $925	43 Added 10.21%	464 $9,000
Q4 2017 Feb 08, 2018	BUY	$18.31 - $22.24 $164 - $200	9 Added 2.18%	421 $8,000
Q3 2017 Nov 06, 2017	BUY	$20.12 - $21.88 $8,289 - $9,014	412	412 $9,000

Others Institutions Holding HQL

# of Institutions

80

Shares Held

9.03M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$50.5 Million
0.82% of portfolio
Morgan Stanley New York, NY

490K
Shares

$7.21 Million
0.0% of portfolio
1607 Capital Partners, LLC Richmond, VA

419K
Shares

$6.17 Million
0.53% of portfolio
Karpus Management, Inc. Pittsford, NY

404K
Shares

$5.95 Million
0.18% of portfolio
Needham Investment Management LLC New York, NY

342K
Shares

$5.03 Million
0.42% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.